Effect of reorganized-human growth hormone on cell cycle kinetics in liver cancer in vitro

Hepatobiliary and Pancreatic Diseases International

Volumn 1, Issue 2, 2002, Pages 224-227

  He, Xin Yang ^a   Xu, Ge Liang ^a   Xu, Rong Nan ^a   Ze, Zhi Min ^a  

^a ANHUI PROVINCIAL HOSPITAL   (China)

Author keywords

Apoptosis; Cell cyle kinetics; Liver cancer; Reorganized human growth hormone

Indexed keywords

CISPLATIN; GROWTH FACTOR RECEPTOR; HUMAN GROWTH HORMONE;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CHEMOTHERAPY; CELL CULTURE; CELL CYCLE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL DIFFERENTIATION; CELL KINETICS; CELL STRAIN; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA CONTENT; DRUG EFFECT; DRUG SAFETY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IN VITRO STUDY; LIVER CANCER; LIVER CELL; PROTEIN EXPRESSION; STATISTICAL ANALYSIS;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL CYCLE; CISPLATIN; DNA, NEOPLASM; DRUG SYNERGISM; FLUORESCENCE; HUMAN GROWTH HORMONE; HUMANS; KINETICS; LIVER NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 0038205725     PISSN: 14993872     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (4)

1. Han R, Ed. Prevention of tumor by emboden chemotherapy. Beijing: United Publishing House of Beijing Medical University and Peking Union Medical School. 1991,131-138.
2. Zhang SB, Zhang LY. The sensitivity and the resistance to the action of drug of emboden chemotherapy for tumor. Chengdu: Sichuan Science and Technology Publishing Press. 1995,78-79.
3. Yoshimura Y, Washita M, Karube M, et al. Growth hormone stimulates follicular development by stimulating ovarian production of insulin-like growth factor I. Endocrinology 1994;135:887-894.
4. Chang TC, Lin JJ, Yu SC, et al. Absence of growth-hormone receptor in hepatocellular carcinoma and cirrhotic liver. Hepatology 1990;11:123-126.